France's LEEM launches election blog

8 April 2007

The French drug industry trade association (LEEM) has launched a web log or "blog," to encourage voters to participate in the group's debate on the future of health care, as part of the run-up to the presidential elections.

By the end of March, the web site www.2007prioritesante.com had received about 3,000 visits and from the comments, the LEEM says that three major themes are emerging: the importance of ensuring funding for R&D which rewards innovation; the construction of ambitious national programs to give France "resources proportionate with its health goals;" and allowing the speedy access of new products to patients.

The LEEM said that the blog will continue to operate in the weeks preceding the election of the new President to replace Jacques Chirac. In the meantime, the drug industry body is hosting a public debate with representatives of most of the leading candidates on April 4, at the Maison de la Mutualite in Paris, which, in addition to being the headquaters of the non-profit insurers federation, is a conference center often used for major political party events. About 500 people are expected to attend the event.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight